Last update 01 Nov 2024

AbbVie (Pty) Ltd. (South Africa)

Subsidiary Company|
South Africa

Overview

Tags

Other Diseases
Congenital Disorders
Nervous System Diseases
Small molecule drug
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Infectious Diseases1
Immune System Diseases1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Monoclonal antibody1
Top 5 TargetCount
DDC x DRDs1
TNF-α(Tumor necrosis factor α)1

Related

2
Drugs associated with AbbVie (Pty) Ltd. (South Africa)
Adalimumab
Target
TNF-α
Mechanism
TNF-α inhibitors
Active Org.
AbbVie (Pty) Ltd. (South Africa) [+3]
Originator Org.
AbbVie, Inc.AbbVie, Inc.
Active Indication
Pyoderma Gangrenosum [+17]
Inactive Indication
Axial Spondyloarthritis [+15]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date31 Dec 2002
Carbidopa/Levodopa
Target
DDC x DRDs
Mechanism
DDC inhibitors [+1]
Active Org.
Daito Pharmaceutical Co., Ltd.Daito Pharmaceutical Co., Ltd. [+14]
Originator Org.
Merck & Co., Inc.Merck & Co., Inc.
Active Indication
Parkinsonian Disorders [+7]
Inactive Indication
Complication [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date02 May 1975
4
Clinical Trials associated with AbbVie (Pty) Ltd. (South Africa)
ACTRN12619000280101
/ RecruitingPhase 2IIT
AMLM22/D2-The International Acute myeloid leukaemia (AML) Platform Consortium (IAPC) trial is a randomised, multi-arm study platform to compare the efficacy of experimental therapies versus standard of care in subjects with acute myeloid leukaemia in first complete remission. Domain 2 is investigating the safety and efficacy of Venetoclax as a maintenance therapy alone or in combination with low dose cytarabine (LDAC).
ACTRN12615000812594
/ CompletedNot Applicable
A two stage, epidemiological, cross-sectional survey study of the Australian population, to determine the prevalence and severity of Hidradenitis Suppurativa (HS).
ACTRN12615000030572
/ CompletedNot Applicable
Hurley staging versus self administered questionnaire to determine the severity of Hydradentitis Suppurativa
100 Clinical Results associated with AbbVie (Pty) Ltd. (South Africa)
Login to view more data
0 Patents (Medical) associated with AbbVie (Pty) Ltd. (South Africa)
Login to view more data
100 Deals associated with AbbVie (Pty) Ltd. (South Africa)
Login to view more data
100 Translational Medicine associated with AbbVie (Pty) Ltd. (South Africa)
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Adalimumab
 ( TNF-α )		Rheumatoid Arthritis
More
Approved
Carbidopa/Levodopa
 ( DDC x DRDs )		Parkinson Disease
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free